Global trends and hotspots in IgA nephropathy: a bibliometric analysis and knowledge map visualization from 2012 to 2023
暂无分享,去创建一个
[1] B. Rovin,et al. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. , 2022, Kidney international.
[2] Lingqiu Dong,et al. Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling , 2022, Journal of translational medicine.
[3] Yafeng Li,et al. Fecal Capsule as a Therapeutic Strategy in IgA Nephropathy: A Brief Report , 2022, Frontiers in Medicine.
[4] Chaomei Chen,et al. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends , 2022, Neuroscience & Biobehavioral Reviews.
[5] G. Celano,et al. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy , 2021, Frontiers in Immunology.
[6] B. Rovin,et al. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.
[7] T. Rauen,et al. Current treatment of IgA nephropathy , 2021, Seminars in Immunopathology.
[8] Zhiming Sun,et al. Global Research Trends of Ferroptosis: A Rapidly Evolving Field With Enormous Potential , 2021, Frontiers in Cell and Developmental Biology.
[9] Zhiming Sun,et al. Worldwide research tendency and hotspots on hip fracture: a 20-year bibliometric analysis , 2021, Archives of Osteoporosis.
[10] Shiren Sun,et al. Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports , 2021, Renal failure.
[11] Hong Zhang,et al. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies , 2020, Theranostics.
[12] Andy Wai Kan Yeung,et al. Lignans: Quantitative Analysis of the Research Literature , 2020, Frontiers in Pharmacology.
[13] J. Barratt,et al. Is immunoglobulin A nephropathy different in different ethnic populations? , 2019, Nephrology.
[14] R. Coppo,et al. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] J. Novak,et al. Markers for the progression of IgA nephropathy , 2016, Journal of Nephrology.
[16] S. Lechner,et al. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. , 2015, Kidney international.
[17] Philipp Mayr,et al. Scientometrics and information retrieval: weak-links revitalized , 2014, Scientometrics.
[18] Stefan C. Wolter,et al. The Use of Bibliometrics to Measure Research Performance in Education Sciences , 2012, Research in Higher Education.
[19] B. Julian,et al. The pathophysiology of IgA nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[20] Giovanni Abramo,et al. The field-standardized average impact of national research systems compared to world average: the case of Italy , 2011, Scientometrics.
[21] Ludo Waltman,et al. Vosviewer: A Computer Program for Bibliometric Mapping , 2009 .
[22] Chaomei Chen,et al. Searching for intellectual turning points: Progressive knowledge domain visualization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] W. Owen,et al. Evidence for genetic factors in the development and progression of IgA nephropathy. , 2000, Kidney international.
[24] R. Coppo,et al. Dietary antigens and primary immunoglobulin A nephropathy. , 1992, Journal of the American Society of Nephrology : JASN.
[25] Jian Mou. BIBLIOMETRIC AND VISUALIZED ANALYSIS OF RESEARCH ON MAJOR E-COMMERCE JOURNALS USING CITESPACE , 2019 .
[26] Chaomei Chen,et al. CiteSpace II: Visualization and Knowledge Discovery in Bibliographic Databases , 2005, AMIA.
[27] P. Zucchelli,et al. [IgA nephropathy]. , 1985, Medicina clinica.